by Emily Bass, Judy Auerbach, Jared Baeten et al.
Global Advocacy for HIV Prevention (AVAC), December 2013
48 pp. 3.1 MB:
This report’s central focus is the search for female-initiated prevention options. Today, there are only three ongoing efficacy trials of biomedical prevention strategies – and all of them involve vaginal microbicides. These trials are being tracked with interest and concern, in large part because of adherence challenges in some recent studies. Whether positive or not, the results will shape the field. But we cannot wait until the data are in to take action. Now is the time to articulate a broad and ambitious approach to finding new prevention tools for women.